Thursday, November 15, 2012
Print Current Session:
|
|
Thursday
SESSION 16:
INTERVENTIONAL RADIOLOGISTS’ ROLE IN THE MANAGEMENT OF METASTATIC DISEASE
Moderators:Andreas Kaubisch, MD / Jacob Cynamon, MD
|
|
SESSION 16 SCHEDULE | |
1:30 PM - 1:40 PM | Colorectal Mets Management: An Overview |
Presenter(s):Andreas Kaubisch, MD | |
1:40 PM - 1:50 PM | When Is Surgical Resection Best? |
Presenter(s):Milan Kinkhabwala, MD | |
1:50 PM - 2:00 PM | Portal Vein Embolization: Indications, Tips And Tricks |
Presenter(s):David C. Madoff, MD | |
2:00 PM - 2:10 PM | Why Y90 Should Be The Treatment Of Choice For Most Metastatic Liver Lesions |
Presenter(s):Matthew S. Johnson, MD | |
2:10 PM - 2:20 PM | Tailored Radioembolization: Diffuse Liver vs. Lobectomy |
Presenter(s):Daniel Y. Sze, MD, PhD | |
2:20 PM - 2:30 PM | Technical Considerations For Optimizing Y90 Outcomes |
Presenter(s):Riad Salem, MD, MBA | |
2:30 PM - 2:40 PM | Role Of DEBIRI/Ablation: Current Role Of Combination Therapy In CRC Liver Mets |
Presenter(s):Riccardo Lencioni, MD | |
2:40 PM - 2:50 PM | Metastatic Disease: When Should You Use TACE, Y90 Or ChemoSaturation? |
Presenter(s):Daniel B. Brown, MD | |
2:50 PM - 3:00 PM | US Experience With ChemoSaturation |
Presenter(s):Krishna kandarpa, MD, PhD | |
3:00 PM - 3:10 PM | Initial European Institute of Oncology (EIO) Experience With Hepatic ChemoSaturation |
Presenter(s):Pier Francesco Ferrucci, MD, PhD | |
3:10 PM - 3:20 PM | Panel Discussion |
END OF SESSION 16 | |
previous | next |